Skip to content

Ritonavir

Ritonavir (Kaletra) is a protease inhibitor used in combination with other antiretrovirals to treat HIV-1 infection. This page lists the one formulation available in the catalogue.

Kaletra

Human Immunodeficiency Virus 1 (HIV-1) Infection

200mg + 50mg

A lopinavir and ritonavir tablet for HIV-1 infection. Ritonavir prolongs the effect of lopinavir, so the two are paired.

From$3.45/ tabletView

Key points

  • The ritonavir and lopinavir combination is available as a single tablet, with the originator brand Kaletra marketed by AbbVie.
  • Ritonavir belongs to the protease inhibitor class of antiretroviral medicines, which block an enzyme HIV needs to reproduce.

What Ritonavir is used for

Ritonavir is listed for HIV-1 infection, where it is used together with other antiretroviral medicines as part of a combination regimen within HIV Management.

Further reading